MIAMI– Ostro, the only customer-facing agentic AI platform built for the life sciences industry, has launched a new digital experience that integrates its flagship engagement tools, Tailor and Navigate. The redesigned platform transforms pharmaceutical websites from static information hubs into intelligent, responsive tools that provide healthcare providers (HCPs) and patients with faster, more reliable access to medical information.
The unified experience combines Ostro’s conversational AI chat tool with its advanced search capabilities into a single interface. By doing so, the company aims to address rising expectations around usability, personalization and clarity as adoption of AI in healthcare continues to expand. Research shows that two out of three HCPs already use AI in daily workflows, while more than 15 percent of patients turn to tools such as ChatGPT for medical advice.
With its enhanced platform, Ostro says drug manufacturers can deliver compliant, actionable answers to complex pharmaceutical questions in real time, while maintaining FDA-aligned standards. Unlike general-purpose large language models, the company notes its tools maintain a 0 percent hallucination rate and outperform traditional bots and enterprise search functions.
“Ostro’s entire suite of products was purpose-built for the unique needs of the life sciences industry,” said Gurjeev Singh, Head of Product at Ostro. “Executing effective go-to-market and brand strategies starts with an understanding of the challenges facing your target audience. With this enhanced experience, HCPs no longer have to dreadfully sift through packets of information to make the best treatment decision, and patients benefit from immediate access to valuable tools and resources like savings cards and pharmacy locators.”
The platform’s redesign was informed by extensive user research, behavioral analytics and competitive benchmarking, developed alongside partnerships with ten of the top 20 global pharmaceutical companies. Ostro identified an industry-wide need for greater clarity, utility and efficiency in how providers and patients interact with branded websites.
“This project helped us rethink how AI shapes engagement. We’re aiming to meet customers where they are, with the clarity, speed, and convenience they need,” said Matt Balogh, Head of Digital Marketing at Melinta Therapeutics. “Ostro’s platform flips traditional digital engagement on its head — not just more clicks and time-on-site, but real answers, faster. Their team has been knowledgeable, flexible, and collaborative throughout. They’ve been true partners in shaping how we approach AI.”
